In following their business tagline of Improving Care. Improving Business®, DeRoyal announces the release of their newest product, the RadAR® EasyClik®
Wrist Vascular Compression Device. Concerned that heart disease remains
one of the leading causes of death worldwide, DeRoyal continues to
dedicate their expertise to expanding and improving their angiographic
product line. This single-use device provides a safe, quick and easy
method of achieving hemostasis for post catheterization radial access
patients through basic circumferential compression around the wrist in a
bracelet like device.
Trans radial catheterization (through the
radial artery in the wrist) has many clinical advantages over the more
traditional trans femoral (through the femoral artery in the groin)
including fewer bleeding complications and earlier ambulation of the
patient. As a result, the radial access approach has become
increasingly popular over the last several years. This approach does
require some special supplies, one of which is a device to help stop the
bleeding at the puncture site in the wrist.
The easy to use RadAR® EasyClik®
includes a strap that has housing, adjustment levers, and a translucent
compression pad for conveniently applying external compression to the
puncture site, and a cushion pad for patient comfort. With the
adjustment levers, the clinician can quickly make a one-handed
compression adjustment to permit patent blood flow through the artery
and gradually release pressure during hemostasis without unfastening the
device.
David Watermeier, Senior Director of International
Marketing stated, “In the US, angiography procedures performed through
the femoral artery are the norm. In many countries outside the United
States, such as Brazil, Canada, Japan, Australia and much of Europe,
these procedures are being done via radial artery access the
overwhelming majority of the time. This product represents a unique
opportunity for DeRoyal’s International division. This is a fantastic
product that is simple-to-use, very efficient in its performance, and
will prove to be a cost savings for many cath labs in the markets we
serve.”